Viewing StudyNCT06177522



Ignite Creation Date: 2024-05-06 @ 7:53 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06177522
Status: RECRUITING
Last Update Posted: 2023-12-20
First Post: 2023-12-11

Brief Title: Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
Sponsor: Jinling Hospital China
Organization: Jinling Hospital China

Conditions & Keywords Data

Conditions:
Name
Neoadjuvant Therapy
Pancreatic Cancer
Keywords: